Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age

Cytotherapy

Volumn 9, Issue 4, 2007, Pages 348-355

  Milone, G ^a   Mercurio, S ^a   Strano, A ^a   Leotta, S ^a   Pinto, V ^a   Battiato, K ^a   Coppoletta, S ^a   Murgano, P ^a   Farsaci, B ^a   Privitera, A ^a   Giustolisi, R ^a  

^a Ospedale Ferrarotto   (Italy)

Author keywords

Adverse events; HPC

Indexed keywords

BUSULFAN; CARMUSTINE; CHLORPHENIRAMINE; CYTARABINE; ETOPOSIDE; HYDROCORTISONE; MELPHALAN;

ABDOMINAL PAIN; ACUTE LEUKEMIA; ADULT; AGE; AGED; APHERESIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL SUSPENSION; CHILD; CHILL; CONTROLLED STUDY; COUGHING; CRYOPRESERVATION; DIARRHEA; DIZZINESS; DRUG MEGADOSE; ERYTHROCYTE CONCENTRATE; FEMALE; FEVER; HEADACHE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; HUMAN CELL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NAUSEA AND VOMITING; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RASH;

ADOLESCENT; ADULT; AGED; AGING; BLOOD COMPONENT REMOVAL; BLOOD PRESSURE; BONE MARROW CELLS; CARDIOVASCULAR SYSTEM; CHILD; CRYOPRESERVATION; FEMALE; HEART RATE; HEMATOCRIT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; L-LACTATE DEHYDROGENASE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED;

EID: 34347209793     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240701326756     Document Type: Article

References (25)

1. Zambelli, A., Da Prada, G. and Pedrazzoli, P. (1998) Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res, 18, pp. 4705-4708.
2. Keung, YK, Lau, S. and Elkayam, U. (1994) Cardiac arrhythmia after infusion of cryopreserved stem cells. Bone Marrow Transplant, 14, pp. 363-367.
3. Stroncek, DF, Fautsch, SK and Lasky, LC (1991) Adverse reactions in patients transfused with cryopreserved marrow. Transfusion, 31, pp. 521-526.
4. Alessandrino, P., Bernasconi, P. and Caldera, D. (1999) Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: Analysis of 126 cases. Bone Marrow Transplant, 23, pp. 533-537.
5. Davis, JM, Rowley, SD and Braine, HG (1990) Clinical toxicity of cryopreserved bone marrow graft infusion. Blood, pp. 781-786.
6. Lopez-Jimenez, J., Cervero, C. and Munoz, A. (1994) Cardiovascular toxicities related to the infusion of cryopreserved grafts: Results of a controlled study. Bone Marrow Transplant, 13, pp. 789-793.
7. Graves, V., Danielson, CFM, Abonour, R. and McCarthy, LJ. (1998) How to ensure safe and well-tolerated stem cell infusions. Transfusion, 38, pp. 30S-5S.
8. Kessinger, A., Armitage, JO and Smith, DM (1989) High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood, 74, pp. 1260-1265.
9. Dhodapkar, M., Goldberg, SL, Tefferi, A. and Gertz, MA. (1994) Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol, 45, pp. 187-188.
10. Hoyt, R., Szer, J. and Grigg, A. (2000) Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant, 25, pp. 1285-1287.
11. Burger, J., Gilmore, MJ, Jackson, B. and Prentice, HG. (1991) Acute haemoglobinaemia associated with the reinfusion of bone marrow buffy coat for autologous bone marrow transplantation. Bone Marrow Transplant, 7, pp. 322-324.
12. Styler, MJ, Topolsky, DL and Crilley, PA (1992) Transient high grade heart block following autologous bone marrow infusion. Bone Marrow Transplant, 10, pp. 435-438.
13. Martino, M., Morabito, F. and Messina, G. (1996) Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients. Haematologica, 81, pp. 59-61.
14. Okamoto, Y., Takaue, Y. and Saito, S. (1993) Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer. Transfusion, 33, pp. 578-581.
15. Rapoport, AP, Rowe, JM, Packman, CH and Ginsberg, SJ. (1991) Cardiac arrest after autologous marrow infusion. Bone Marrow Transplant, 7, pp. 401-403.
16. Zenhausern, R., Tobler, A. and Leoncini, L. (2000) Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol, 79, pp. 523-526.
17. Benekli, M., Anderson, B. and Wentling, D. (2000) Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with L amyloidosis. Bone Marrow Transplant, 25, pp. 1299-1301.
18. Klingeman, A. (1965) Topical pharmacology and toxicology of dimethylsulphoxide. JAMA, 193, pp. 140-148.
19. Shlafer, M. and Karow Jr, AM (1975) Pharmacological effects of dimethyl sulfoxide on the mammalian myocardium. Ann NY Acad Sci, 243, pp. 110-121.
20. Chaloupka, JC, Huddle, DC and Alderman, J. (1999) A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model. Am J Neuroradiol, 20, pp. 401-410.
21. Potter, EK, Parker, P., Caine, AC and Lumbers, ER. (1985) Potentiation of cardiac vagal action by cold. Clin Sci (Lond), 68, pp. 165-169.
22. Sauer-Heilborn, A., Kadidlo, D. and McCullough, J. (2004) Patient care during infusion of hematopoietic progenitor cells. Transfusion, 44, pp. 907-916.
23. Milone, G., Leotta, S. and Indelicato, F. (2003) G-CSF alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: Results depend on degree of previous pretreatment. Bone Marrow Transplant, 31, pp. 747-754.
24. Shlafer, M. and Karow, AM. (1975) Pharmacological effects of dimethyl sulfoxide on the mammalian myocardium. Ann NY Acad Sci, 243, pp. 110-121.
25. Calmels, B., Houze, P. and Hengesse, JC (2003) Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing. Bone Marrow Transplant, 31, pp. 823-828.